Dr. Michael DiPrima, LCO Postdoctoral Fellow (CRTA)

Michael DiPrima, Ph.D.

  • Center for Cancer Research
  • National Cancer Institute
Laboratory of Cellular Oncology


Dr. DiPrima’s research is focused on the identification of vulnerabilities in colorectal cancer cells, particularly emerging from Eph receptors activation and tyrosine kinase signaling. Currently, he is exploring small molecule inhibitors to inhibit cancer cell growth.

Areas of Expertise

Cancer Cells
Tyrosine Kinase Receptors
Ephrin Ligands And Eph Receptors
Mouse Models Of Cancer
Tyrosine Kinase Inhibitors